Search
LENZ Therapeutics Inc
LENZAdd to Watchlist
6.150USD
-0.190-3.00%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
192.83MMarket Cap
LossP/E TTM
LENZ Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of LENZ Therapeutics Inc is 7.08, ranking 265 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -1.69, which is -2971.75% below the recent high of 48.49 and -1686.03% above the recent low of -30.16.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
